About
Silvec develops RNA-based therapies for protecting trees, vines, and bushes from viral, bacterial, and fungal diseases without altering the host genome, providing long-lasting protection with a single application.
Explore Silvec's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.